Fungal endocarditis: need for guidelines in evaluating therapy. Experience with two patients previously reported

John N Galgiani, D. A. Stevens

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Successful treatment of fungal endocarditis is being described with increasing frequency. Two patients, previously reported as free of disease by two different groups of investigators, subsequently died with evidence of continued disease. Both patients had been receiving antifungal chemotherapy at the time their case histories were reported. The lack of clinical signs and symptoms in fungal endocarditis, the suppression of manifestations of infection by chemotherapy, and the uncertain reliability of laboratory aids led us to suggest guidelines in reporting results of therapeutic regimens. These include avoidance of terms implying cure in patients who are concurrently maintained on chemotherapy, indication of attempts to evaluate fungemia, and minimum follow up of 1 to 2 years' duration. The potential utility of serologic studies is illustrated by the course of one of these patients.

Original languageEnglish (US)
Pages (from-to)293-296
Number of pages4
JournalJournal of Thoracic and Cardiovascular Surgery
Volume73
Issue number2
StatePublished - 1977
Externally publishedYes

Fingerprint

Endocarditis
Guidelines
Drug Therapy
Fungemia
Therapeutics
Signs and Symptoms
Research Personnel
Infection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

@article{3b92c9a27cc7467a8beb59e31f9a20f1,
title = "Fungal endocarditis: need for guidelines in evaluating therapy. Experience with two patients previously reported",
abstract = "Successful treatment of fungal endocarditis is being described with increasing frequency. Two patients, previously reported as free of disease by two different groups of investigators, subsequently died with evidence of continued disease. Both patients had been receiving antifungal chemotherapy at the time their case histories were reported. The lack of clinical signs and symptoms in fungal endocarditis, the suppression of manifestations of infection by chemotherapy, and the uncertain reliability of laboratory aids led us to suggest guidelines in reporting results of therapeutic regimens. These include avoidance of terms implying cure in patients who are concurrently maintained on chemotherapy, indication of attempts to evaluate fungemia, and minimum follow up of 1 to 2 years' duration. The potential utility of serologic studies is illustrated by the course of one of these patients.",
author = "Galgiani, {John N} and Stevens, {D. A.}",
year = "1977",
language = "English (US)",
volume = "73",
pages = "293--296",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Fungal endocarditis

T2 - need for guidelines in evaluating therapy. Experience with two patients previously reported

AU - Galgiani, John N

AU - Stevens, D. A.

PY - 1977

Y1 - 1977

N2 - Successful treatment of fungal endocarditis is being described with increasing frequency. Two patients, previously reported as free of disease by two different groups of investigators, subsequently died with evidence of continued disease. Both patients had been receiving antifungal chemotherapy at the time their case histories were reported. The lack of clinical signs and symptoms in fungal endocarditis, the suppression of manifestations of infection by chemotherapy, and the uncertain reliability of laboratory aids led us to suggest guidelines in reporting results of therapeutic regimens. These include avoidance of terms implying cure in patients who are concurrently maintained on chemotherapy, indication of attempts to evaluate fungemia, and minimum follow up of 1 to 2 years' duration. The potential utility of serologic studies is illustrated by the course of one of these patients.

AB - Successful treatment of fungal endocarditis is being described with increasing frequency. Two patients, previously reported as free of disease by two different groups of investigators, subsequently died with evidence of continued disease. Both patients had been receiving antifungal chemotherapy at the time their case histories were reported. The lack of clinical signs and symptoms in fungal endocarditis, the suppression of manifestations of infection by chemotherapy, and the uncertain reliability of laboratory aids led us to suggest guidelines in reporting results of therapeutic regimens. These include avoidance of terms implying cure in patients who are concurrently maintained on chemotherapy, indication of attempts to evaluate fungemia, and minimum follow up of 1 to 2 years' duration. The potential utility of serologic studies is illustrated by the course of one of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0017349982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017349982&partnerID=8YFLogxK

M3 - Article

C2 - 834068

AN - SCOPUS:0017349982

VL - 73

SP - 293

EP - 296

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 2

ER -